Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa

Author:

Treurnicht Florette K.1ORCID,Buys Amelia1,Tempia Stefano23ORCID,Seleka Mpho1,Cohen Adam L.24,Walaza Sibongile15,Glass Allison J.6,Rossouw Inéz7,McAnerney Johanna1,Blumberg Lucille58,Cohen Cheryl15,Venter Marietjie910

Affiliation:

1. Centre for Respiratory Diseases and Meningitis; National Institute for Communicable Diseases of the National Health Laboratory Service; Johannesburg South Africa

2. Influenza Division; Centers for Disease Control and Prevention; Atlanta Georgia

3. Influenza Program; Centers for Disease Control and Prevention; Pretoria South Africa

4. Department of Immunization, Vaccines and Biologicals; Global Immunization Monitoring and Surveillance, Expanded Programme on Immunization; World Health Organization; Geneva Switzerland

5. Faculty of Health Sciences; School of Public Health; University of the Witwatersrand; Johannesburg South Africa

6. Department of Molecular Pathology; Lancet Laboratories; Johannesburg South Africa

7. PathCare Laboratories; PathCare Park; Cape Town South Africa

8. Division of Public Health Surveillance and Response; National Institute of Communicable Diseases; Johannesburg South Africa

9. Department of Medical Virology; Emerging Arbo-and Respiratory Virus Program; University of Pretoria; Pretoria South Africa

10. Tshwane Academic Division; National Health Laboratory Service; Pretoria South Africa

Funder

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Reference53 articles.

1. WHO Influenza (Seasonal) fact sheet http://www.who.int/mediacentre/factsheets/fs211/en/

2. Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study;Simonsen;PLoS Med,2013

3. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study;Iuliano;Lancet,2017

4. FDA Relenza 1999 https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21036.cfm

5. FDA Tamiflu 1999 https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21087_Tamiflu.cfm

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3